References
- HelmlingerGYuanFDellianMJainRKInterstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlationNat Med199731771829018236
- Wike-HooleyJLVan der ZeeJvan RhoonGCVan den BergAPReinholdHSHuman tumour pH changes following hyperthermia and radiation therapyEur J Cancer Clin Oncol1984206196236539698
- ShenYTangHRadoszMVan KirkEMurdochWJpH-responsive nanoparticles for cancer drug deliveryMethods Mol Biol200843718321618369970
- GantaSDevalapallyHShahiwalaAAmijiMA review of stimuli-responsive nanocarriers for drug and gene deliveryJ Control Release200812618720418261822
- OnacaOEneaRHughesDWMeierWStimuli-responsive polymersomes as nanocarriers for drug and gene deliveryMacromol Biosci2009912913919107717
- ConnorJYatvinMBHuangLpH-sensitive liposomes: acid-induced liposome fusionProc Natl Acad Sci U S A198481171517186584905
- BaeYNishiyamaNFukushimaSKoyamaHYasuhiroMKataokaKPreparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacyBioconjug Chem20051612213015656583
- OhKTKimDYouHHAhnYSLeeESpH-sensitive properties of surface charge-switched multifunctional polymeric micelleInt J Pharm200937613414019394414
- BaeYFukushimaSHaradaAKataokaKDesign of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH changeAngew Chem Int Ed Engl2003424640464314533151
- NgKKLovellJFZhengGLipoprotein-inspired nanoparticles for cancer theranosticsAcc Chem Res2011441105111321557543
- RyanRONanobiotechnology applications of reconstituted high density lipoproteinJ Nanobiotechnology201082821122135
- MooberryLKNairMParanjapeSMcConathyWJLackoAGReceptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrierJ Drug Target201018535819637935
- CaoWNgKKCorbinISynthesis and evaluation of a stable bacteriochlorophyll analog and its incorporation into high-density lipoprotein nanoparticles for tumor imagingBioconjug Chem2009202023203119839633
- PussinenPJKartenBWinterspergerAThe human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptakeBiochem J200034955956610880355
- SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm200223517919211879753
- DavidsonWSHazlettTMantulinWWJonasAThe role of apolipoprotein AI domains in lipid bindingProc Natl Acad Sci U S A19969313605136108942981
- JayaramanSBenjwalSGantzDLGurskyOEffects of cholesterol on thermal stability of discoidal high density lipoproteinsJ Lipid Res20105132433319700415
- RyanROForteTMOdaMNOptimized bacterial expression of human apolipoprotein A-IProtein Expr Purif2003279810312509990
- ShinJYShinJIKimJSAssembly of Coenzyme Q10 nanostructure resembling nascent discoidal high density lipoprotein particleBiochem Biophys Res Commun200938821722119646960
- LackoAGNairMParanjapeSJohnsoSMcConathyWJHigh density lipoprotein complexes as delivery vehicles for anticancer drugsAnticancer Res2002222045204912174882
- McConathyWJNairMPParanjapeSMooberryLLackoAGEvaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxelAnticancer Drugs20081918318818176115
- GhoshMSinghATXuWSulchekTGordonLIRyanROCurcumin nanodisks: formulation and characterizationNanomedicine2011716216720817125
- RedmondKANguyenTSRyanROAll-trans-retinoic acid nanodisksInt J Pharm200733924625017412536
- TuftelandMRenGRyanRONanodisks derived from amphotericin B lipid complexJ Pharm Sci2008974425443218271034
- EwertKKAhmadABouxseinNFEvansHMSafinyaCRNon-viral gene delivery with cationic liposome-DNA complexesMethods Mol Biol200843315917518679623
- HuangXCaddellRYuBUltrasound-enhanced microfluidic synthesis of liposomesAnticancer Res20103046346620332455
- GaoWChanJMFarokhzadOCpH-Responsive nanoparticles for drug deliveryMol Pharm201071913192020836539
- SlamonDJClarkGMWongSGLevinWJUllrichAMcGuireWLHuman breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogeneScience19872351771823798106
- HolmesFAWaltersRSTheriaultRLPhase II trial of Taxol, an active drug in the treatment of metastatic breast cancerJ Natl Cancer Inst199183179718051683908
- WahlAFDonaldsonKLFairchildCLoss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosisNat Med1996272798564846
- YuDJingTLiuBOverexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinaseMol Cell199825815919844631
- OrjaloAJohanssonHERuthJLStellaris[trade] fluorescence in situ hybridization (FISH) probes: a powerful tool for mRNA detectionNat Meth8
- LattrichCJuhasz-BoessIOrtmannOTreeckODetection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1Oncol Rep20081981181718288420
- TunaMChavez-ReyesATariAMHER2/neu increases the expression of Wilms’ tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cellsOncogene2005241648165215674342
- DominskaMDykxhoornDMBreaking down the barriers: siRNA delivery and endosome escapeJ Cell Sci20101231183118920356929
- SparksDLLund-KatzSPhillipsMCThe charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particlesJ Biol Chem199226725839258471464598
- VarkouhiAKScholteMStormGHaismaHJEndosomal escape pathways for delivery of biologicalsJ Control Release201115122022821078351